TPX, derived from the mangiferin derivative 1,3,6,7-tetraallylloxy ketone, can restore the insulin signaling pathway, increase liver glycogen synthesis, and protect against IR caused by glucose metabolism disorders in liver cells (Fan et al., 2023). The gene discussed is INS; the disease is glucose metabolism disease.